Letter to the Editor: Medicare prescription price negotiations could be a double-edged sword | SummitDaily.com
YOUR AD HERE »

Letter to the Editor: Medicare prescription price negotiations could be a double-edged sword

Carl Ecklund
Frisco

I have seen in the news that many in the U.S. Congress and in President Joe Biden’s administration keep calling for Medicare to negotiate prescription prices.

Many Americans rely on medications, and this, at first, sounded like an idea with good intentions. However, I have come to find out this could have negative implications on patients all across the country and would result in unnecessary government interference in their healthcare.

Ultimately, restrictive government policies could get in the way of progress that many patients and their families need. If the government were to negotiate drug prices under Medicare, resources originally utilized for research and development could be reduced, they say, and this could slow the creation of new cures and treatments.



As a patient, you always hope that there is a new and improved treatment option to help combat your condition. Congress needs to pass policies that support research and not harm the chances of new medications coming to market.


Support Local Journalism

Support Local Journalism

As a Summit Daily News reader, you make our work possible.

Now more than ever, your financial support is critical to help us keep our communities informed. Every contribution, no matter the size, will make a difference.

Your donation will be used exclusively to support quality, local journalism.